Aphria Inc. connects innovation and cannabis.
We're driving the evolution of the cannabis industryTomorrow’s cannabis products will revolutionize the way our patients and consumers integrate cannabis into their lives. Aphria Inc. is bringing breakthrough innovation to the global cannabis market through a focus on untapped opportunities, backed by the latest technologies.
QUICKSTRIP™ ORAL FAST-DISSOLVING DELIVERY SYSTEM
RDT’s innovative QuickStrip™ is an easy-to-use, safe and effective oral fast-dissolving drug delivery system, developed in conjunction with McMaster University through the renowned Adronov Research Group, providing accurate dosing and potency. Aphria Inc. holds the exclusive global preferred rights to license, manufacture, distribute and sell RDT’s QuickStrip™ innovative, proprietary delivery technology for both medical and adult-use cannabis markets.
Aphria Inc. is supplying Tetra BioPharma with dried flower and cannabis oil products with which they are performing clinical trials.
Aphria Inc is producing and supplying high-yield cannabis extracts for Medlab to be used in a human trial of their NanoCelle mucosal spray to test the management of intractable pain in oncology patients – the first trial of its kind globally.
CANNPAL ANIMAL THERAPEUTICS
Aphria Inc. is supplying cannabis oil to CannPal for use in clinical studies related to animal health, including chronic pain in cats and dogs.
HOSPITAL DE PEDIATRIA GARRAHAN
Through its Argentina-based subsidiary, ABP, S.A., Aphria Inc.’s is supplying its renowned CBD oil to Hospital de Pediatria Garrahan, a leading pediatric hospital located in Buenos Aires, for use in a clinical study focused on treating refractory epilepsy in children.